1-170166515-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001136107.2(NTMT2):c.344C>T(p.Ala115Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000329 in 1,552,274 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00017 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000018 ( 0 hom. )
Consequence
NTMT2
NM_001136107.2 missense
NM_001136107.2 missense
Scores
1
4
14
Clinical Significance
Conservation
PhyloP100: 5.67
Genes affected
NTMT2 (HGNC:31932): (N-terminal Xaa-Pro-Lys N-methyltransferase 2) Enables N-terminal protein N-methyltransferase activity. Involved in N-terminal protein amino acid methylation. Located in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.060593694).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NTMT2 | NM_001136107.2 | c.344C>T | p.Ala115Val | missense_variant | 3/4 | ENST00000439373.3 | NP_001129579.1 | |
NTMT2 | XM_011509232.3 | c.149C>T | p.Ala50Val | missense_variant | 4/5 | XP_011507534.1 | ||
NTMT2 | XM_011509233.3 | c.149C>T | p.Ala50Val | missense_variant | 5/6 | XP_011507535.1 | ||
NTMT2 | XM_011509234.3 | c.149C>T | p.Ala50Val | missense_variant | 4/5 | XP_011507536.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NTMT2 | ENST00000439373.3 | c.344C>T | p.Ala115Val | missense_variant | 3/4 | 1 | NM_001136107.2 | ENSP00000408058 | P1 | |
NTMT2 | ENST00000367764.3 | n.402C>T | non_coding_transcript_exon_variant | 4/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152092Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
26
AN:
152092
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000440 AC: 7AN: 158926Hom.: 0 AF XY: 0.0000119 AC XY: 1AN XY: 83694
GnomAD3 exomes
AF:
AC:
7
AN:
158926
Hom.:
AF XY:
AC XY:
1
AN XY:
83694
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000179 AC: 25AN: 1400062Hom.: 0 Cov.: 31 AF XY: 0.00000869 AC XY: 6AN XY: 690502
GnomAD4 exome
AF:
AC:
25
AN:
1400062
Hom.:
Cov.:
31
AF XY:
AC XY:
6
AN XY:
690502
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000171 AC: 26AN: 152212Hom.: 0 Cov.: 30 AF XY: 0.000188 AC XY: 14AN XY: 74408
GnomAD4 genome
AF:
AC:
26
AN:
152212
Hom.:
Cov.:
30
AF XY:
AC XY:
14
AN XY:
74408
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2021 | The c.344C>T (p.A115V) alteration is located in exon 3 (coding exon 3) of the METTL11B gene. This alteration results from a C to T substitution at nucleotide position 344, causing the alanine (A) at amino acid position 115 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
D
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
D
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at